Jubilant Ingrevia Limited (BOM:543271)
625.75
+7.80 (1.26%)
At close: Jun 9, 2026
Jubilant Ingrevia Revenue
In the fiscal year ending March 31, 2026, Jubilant Ingrevia had annual revenue of 43.88B INR with 5.04% growth. Jubilant Ingrevia had revenue of 11.79B in the quarter ending March 31, 2026, with 12.12% growth.
Revenue
43.88B
Revenue Growth
+5.04%
P/S Ratio
2.25
Revenue / Employee
20.51M
Employees
2,139
Market Cap
98.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 43.88B | 2.10B | 5.04% |
| Mar 31, 2025 | 41.78B | 418.20M | 1.01% |
| Mar 31, 2024 | 41.36B | -6.37B | -13.34% |
| Mar 31, 2023 | 47.73B | -1.77B | -3.57% |
| Mar 31, 2022 | 49.49B | 42.65B | 623.45% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Godrej Industries | 259.81B |
| Deepak Fertilisers And Petrochemicals Corporation | 115.06B |
| Sudarshan Chemical Industries | 97.87B |
| Atul Ltd | 62.74B |
| Thirumalai Chemicals | 17.54B |
| Camlin Fine Sciences | 17.23B |
| Vishnu Chemicals | 16.10B |
| Punjab Chemicals and Crop Protection | 10.30B |
Jubilant Ingrevia News
- 15 days ago - Jubilant Ingrevia Transcript: Q4 25/26 - Transcripts
- 15 days ago - Jubilant Ingrevia Quarterly report: Q4 2026 - Filings
- 15 days ago - Jubilant Ingrevia Slides: Q4 2026 - Filings
- 15 days ago - Jubilant Ingrevia reports 12% revenue growth in Q4 FY26 with ₹1,179 crore - Business Upturn
- 7 weeks ago - Jubilant Ingrevia grants 3,43,569 stock options under employee plan - Business Upturn
- 2 months ago - Jubilant Ingrevia completes acquisition of 100% stake in Remidex Pharma - Business Upturn
- 2 months ago - Jubilant Ingrevia's subsidiary begins commercial production at Bharuch site - Business Upturn
- 3 months ago - Jubilant Ingrevia to acquire Remidex Pharma for Rs 16.5 crore - Business Upturn